Cargando…
Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses
PURPOSE: To investigate if a traditional Chinese medicine formulation, called “Yiqihuoxue” (YQHX), could improve diabetic atherosclerosis (DA) and explore potential mechanisms based on DNA methylation. METHODS: Apolipoprotein E-knockout mice were administered streptozotocin (50 mg/d, i.p.) for 5 day...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754469/ https://www.ncbi.nlm.nih.gov/pubmed/35035227 http://dx.doi.org/10.2147/JIR.S335374 |
_version_ | 1784632279352475648 |
---|---|
author | Zhou, Qing-Bing Chen, Yao Zhang, Yan Li, Dan-Dan Wang, Hong-Qin Jia, Zi-Jun Jin, Yu Xu, Feng-Qin Zhang, Ying |
author_facet | Zhou, Qing-Bing Chen, Yao Zhang, Yan Li, Dan-Dan Wang, Hong-Qin Jia, Zi-Jun Jin, Yu Xu, Feng-Qin Zhang, Ying |
author_sort | Zhou, Qing-Bing |
collection | PubMed |
description | PURPOSE: To investigate if a traditional Chinese medicine formulation, called “Yiqihuoxue” (YQHX), could improve diabetic atherosclerosis (DA) and explore potential mechanisms based on DNA methylation. METHODS: Apolipoprotein E-knockout mice were administered streptozotocin (50 mg/d, i.p.) for 5 days and fed a high-fat diet for 16 weeks. Mice were divided randomly into DA model, rosiglitazone, as well as low-, medium-, and high-dose YQHX groups. Ten healthy C57BL/6J mice were the control group. Serum levels of fasting insulin, blood glucose, homeostasis model-insulin resistance index (HOMA-IR), serum lipids, and inflammatory factors were analyzed after the final treatment. Aorta tissues were collected for staining (hematoxylin and eosin, and Oil red O). Genomic DNA was extracted for methyl-capture sequencing (MC-seq). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) databases were used to analyze differentially methylated genes. Pyrosequencing was used to verify MC-seq data. RESULTS: Low-dose and high-dose YQHX could reduce the HOMA-IR (P < 0.05). Low-dose YQHX reduced expression of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), TNF-α, andI L-6 in serum compared with that in the model group (P < 0.05). Medium-dose YQHX decoction inhibited the expression level of TNF-α (P < 0.05). High-dose YQHX decreased the expression level of IL-6 (P < 0.05). Staining also showed the anti-atherosclerosis effects of YQHX (P < 0.05). MC-seq revealed many abnormally hypermethylated and hypomethylated genes in DA mice compared with those in the control group. KEGG database analysis showed that the hypermethylated genes induced by YQHX treatment were related to pathways in cancer, Hippo signaling, and mitogen activated protein kinase. The network analysis suggested that the hypermethylated genes epidermal growth factor receptor(Egfr) and phosphoinositide-3-kinase regulatory subunit 1(Pik3r1) induced by YQHX treatment had important roles in DA. Pyrosequencing revealed that YQHX treatment increased methylation of AKT1, Nr1h3 and Fabp4 significantly (P < 0.05). CONCLUSION: YQHX decoction had positive treatment effects against DA, because it could regulate aberrant hypomethylation of DNA. |
format | Online Article Text |
id | pubmed-8754469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-87544692022-01-13 Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses Zhou, Qing-Bing Chen, Yao Zhang, Yan Li, Dan-Dan Wang, Hong-Qin Jia, Zi-Jun Jin, Yu Xu, Feng-Qin Zhang, Ying J Inflamm Res Original Research PURPOSE: To investigate if a traditional Chinese medicine formulation, called “Yiqihuoxue” (YQHX), could improve diabetic atherosclerosis (DA) and explore potential mechanisms based on DNA methylation. METHODS: Apolipoprotein E-knockout mice were administered streptozotocin (50 mg/d, i.p.) for 5 days and fed a high-fat diet for 16 weeks. Mice were divided randomly into DA model, rosiglitazone, as well as low-, medium-, and high-dose YQHX groups. Ten healthy C57BL/6J mice were the control group. Serum levels of fasting insulin, blood glucose, homeostasis model-insulin resistance index (HOMA-IR), serum lipids, and inflammatory factors were analyzed after the final treatment. Aorta tissues were collected for staining (hematoxylin and eosin, and Oil red O). Genomic DNA was extracted for methyl-capture sequencing (MC-seq). Kyoto Encyclopedia of Genes and Genomes (KEGG) and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) databases were used to analyze differentially methylated genes. Pyrosequencing was used to verify MC-seq data. RESULTS: Low-dose and high-dose YQHX could reduce the HOMA-IR (P < 0.05). Low-dose YQHX reduced expression of total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), TNF-α, andI L-6 in serum compared with that in the model group (P < 0.05). Medium-dose YQHX decoction inhibited the expression level of TNF-α (P < 0.05). High-dose YQHX decreased the expression level of IL-6 (P < 0.05). Staining also showed the anti-atherosclerosis effects of YQHX (P < 0.05). MC-seq revealed many abnormally hypermethylated and hypomethylated genes in DA mice compared with those in the control group. KEGG database analysis showed that the hypermethylated genes induced by YQHX treatment were related to pathways in cancer, Hippo signaling, and mitogen activated protein kinase. The network analysis suggested that the hypermethylated genes epidermal growth factor receptor(Egfr) and phosphoinositide-3-kinase regulatory subunit 1(Pik3r1) induced by YQHX treatment had important roles in DA. Pyrosequencing revealed that YQHX treatment increased methylation of AKT1, Nr1h3 and Fabp4 significantly (P < 0.05). CONCLUSION: YQHX decoction had positive treatment effects against DA, because it could regulate aberrant hypomethylation of DNA. Dove 2022-01-08 /pmc/articles/PMC8754469/ /pubmed/35035227 http://dx.doi.org/10.2147/JIR.S335374 Text en © 2022 Zhou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhou, Qing-Bing Chen, Yao Zhang, Yan Li, Dan-Dan Wang, Hong-Qin Jia, Zi-Jun Jin, Yu Xu, Feng-Qin Zhang, Ying Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses |
title | Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses |
title_full | Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses |
title_fullStr | Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses |
title_full_unstemmed | Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses |
title_short | Hypermethylation Effects of Yiqihuoxue Decoction in Diabetic Atherosclerosis Using Genome-Wide DNA Methylation Analyses |
title_sort | hypermethylation effects of yiqihuoxue decoction in diabetic atherosclerosis using genome-wide dna methylation analyses |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754469/ https://www.ncbi.nlm.nih.gov/pubmed/35035227 http://dx.doi.org/10.2147/JIR.S335374 |
work_keys_str_mv | AT zhouqingbing hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT chenyao hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT zhangyan hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT lidandan hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT wanghongqin hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT jiazijun hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT jinyu hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT xufengqin hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses AT zhangying hypermethylationeffectsofyiqihuoxuedecoctionindiabeticatherosclerosisusinggenomewidednamethylationanalyses |